Thrivent Financial for Lutherans
MRVI icon

Thrivent Financial for Lutherans’s Maravai LifeSciences MRVI Stock Holding History

Thrivent Financial for Lutherans’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-214,645
Closed -$1.78M – 2584
2024
Q3 		$1.78M Buy
214,645
+26,885
+14% +$232K ﹤0.01% 1529
2024
Q2 		$1.34M Buy
187,760
+11,874
+7% +$103K ﹤0.01% 1659
2024
Q1 		$1.52M Sell
175,886
-125,009
-42% -$846K ﹤0.01% 1618
2023
Q4 		$1.97M Sell
300,895
-11,537,474
-97% -$74.5M ﹤0.01% 1378
2023
Q3 		$118M Buy
11,838,369
+3,533,237
+43% +$38.8M 0.28% 82
2023
Q2 		$103M Buy
8,305,132
+115,334
+1% +$1.56M 0.24% 110
2023
Q1 		$115M Buy
8,189,798
+2,011,683
+33% +$28.9M 0.28% 87
2022
Q4 		$88.4M Buy
6,178,115
+3,618,369
+141% +$57M 0.23% 113
2022
Q3 		$65.3M Buy
+2,559,746
New +$64.2M 0.18% 159
2022
Q1 		– Sell
-20,854
Closed -$874K – 2524
2021
Q4 		$874K Buy
+20,854
New +$845K ﹤0.01% 1932

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Thrivent Financial for Lutherans's MRVI Position: Q4 2024 in Review

Thrivent Financial for Lutherans sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 214,645 shares — an estimated $1.78M sold.

Thrivent Financial for Lutherans first reported a position in MRVI in Q4 2021 and held it in 10 quarters. The position peaked at $118M in Q3 2023. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • Thrivent Financial for Lutherans reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 214,645 Maravai LifeSciences shares in Q4 2024, an estimated $1.78M.
  • Thrivent Financial for Lutherans first reported a position in Maravai LifeSciences in Q4 2021 and held it in 10 quarters.
  • Thrivent Financial for Lutherans's Maravai LifeSciences position peaked at $118M in Q3 2023.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2024, filed 10 Feb 2025.